Page last updated: 2024-11-04

vorinostat and Proteinuria

vorinostat has been researched along with Proteinuria in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reilly, CM1
Mishra, N1
Miller, JM1
Joshi, D1
Ruiz, P1
Richon, VM1
Marks, PA1
Gilkeson, GS1

Other Studies

1 other study available for vorinostat and Proteinuria

ArticleYear
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Sep-15, Volume: 173, Issue:6

    Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; CD3 Comple

2004